drugset / Trial / NCT01104493

A Clinical Study to Assess the Safety of a New Influenza Vaccine

NCT01104493 ↗

Phase 4 Completed 300 enrolled MedImmune LLC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To assess the safety of a new influenza virus vaccine containing a new virus strain in healthy patients prior to the release of the vaccine.

Timeline

Start
2010-05
Primary completion
2010-06
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Monovalent Frozen FluMist® Vaccine — Intranasal

Indications

No indication recorded.